Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Paillard

Showing results (11-20 of 120) with videos related to

Pageof 12
Sort By:
Human Gene Therapy|July 29, 1998
Activation of retrovirally transduced T lymphocytesF Paillard
Human Gene Therapy|August 28, 1998
Adenoviral vector persistence in vivo with a soluble form of CTLA4F Paillard
Human Gene Therapy|May 1, 1999
Somatostatin receptor gene transfer induces bystander effectsF Paillard
Human Gene Therapy|April 11, 2000
Immunosuppression mediated by tumor cells: a challenge for immunotherapeutic approachesF Paillard
Human Gene Therapy|February 18, 1999
Immunotherapy with T cells bearing chimeric antitumor receptorsF Paillard
Human Gene Therapy|February 27, 1999
Glycotargeting: a receptor-mediated delivery using sugar ligandsF Paillard
Human Gene Therapy|July 3, 1998
Cancer cells under the fire of combined therapiesF Paillard
Human Gene Therapy|March 4, 2000
Engineering cells for glucose-sensitive production of insulin: toward genetic reconstructionF Paillard
Human Gene Therapy|August 7, 1998
Enhancement of the Fas death pathway in tumor cells: an approach to cancer treatmentF Paillard
Human Gene Therapy|August 7, 1998
Inhibition of Fas death pathway in cytotoxic T cells: an approach to prevent graft-versus-host diseaseF Paillard
Pageof 12

Showing results (11-20 of 120) with videos related to

Sort By:
Pageof 12
Human Gene Therapy|July 29, 1998
Activation of retrovirally transduced T lymphocytesF Paillard
Human Gene Therapy|August 28, 1998
Adenoviral vector persistence in vivo with a soluble form of CTLA4F Paillard
Human Gene Therapy|May 1, 1999
Somatostatin receptor gene transfer induces bystander effectsF Paillard
Human Gene Therapy|April 11, 2000
Immunosuppression mediated by tumor cells: a challenge for immunotherapeutic approachesF Paillard
Human Gene Therapy|February 18, 1999
Immunotherapy with T cells bearing chimeric antitumor receptorsF Paillard
Human Gene Therapy|February 27, 1999
Glycotargeting: a receptor-mediated delivery using sugar ligandsF Paillard
Human Gene Therapy|July 3, 1998
Cancer cells under the fire of combined therapiesF Paillard
Human Gene Therapy|March 4, 2000
Engineering cells for glucose-sensitive production of insulin: toward genetic reconstructionF Paillard
Human Gene Therapy|August 7, 1998
Enhancement of the Fas death pathway in tumor cells: an approach to cancer treatmentF Paillard
Human Gene Therapy|August 7, 1998
Inhibition of Fas death pathway in cytotoxic T cells: an approach to prevent graft-versus-host diseaseF Paillard
Pageof 12